Bank of America Corp DE Acquires 171,554 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
Bank of America Corp DE Acquires 171,554 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
Bank of America Corp DE increased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 36.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 639,632 shares of the medical instruments supplier's stock after purchasing an additional 171,554 shares during the period. Bank of America Corp DE's holdings in West Pharmaceutical Services were worth $262,703,000 at the end of the most recent quarter.
根据美国银行最近向美国证券交易委员会(Securities and Exchange Commission，美国证券交易委员会)提交的文件，该公司在第一季度增持了West Pharmtics Services，Inc.(纽约证券交易所代码：WST-GET评级)的股票36.7%。该机构投资者持有这家医疗器械供应商的639,632股股票，在此期间又购买了171,554股。截至最近一个季度末，美国银行(Bank Of America Corp DE)在West Pharmtics Services持有的股份价值262,703,000美元。
Several other institutional investors have also modified their holdings of WST. ARK Investment Management LLC acquired a new stake in West Pharmaceutical Services in the 1st quarter valued at approximately $179,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in West Pharmaceutical Services in the 1st quarter valued at approximately $4,412,000. National Asset Management Inc. raised its position in West Pharmaceutical Services by 11.9% in the 1st quarter. National Asset Management Inc. now owns 2,269 shares of the medical instruments supplier's stock valued at $933,000 after buying an additional 241 shares during the last quarter. Kestra Advisory Services LLC raised its position in West Pharmaceutical Services by 7.5% in the 1st quarter. Kestra Advisory Services LLC now owns 3,124 shares of the medical instruments supplier's stock valued at $1,283,000 after buying an additional 219 shares during the last quarter. Finally, Mutual of America Capital Management LLC raised its position in West Pharmaceutical Services by 1.1% in the 1st quarter. Mutual of America Capital Management LLC now owns 9,904 shares of the medical instruments supplier's stock valued at $4,068,000 after buying an additional 104 shares during the last quarter. Institutional investors own 91.98% of the company's stock.
其他几家机构投资者也调整了对WST的持股。方舟投资管理公司在第一季度收购了西方制药服务公司的新股份，价值约为179,000美元。未来资产全球投资有限公司在第一季度收购了西方制药服务公司的新股份，价值约为441.2万美元。National Asset Management Inc.在第一季度将其在West Pharmtics Services的头寸提高了11.9%。National Asset Management Inc.现在持有这家医疗器械供应商2,269股股票，价值93.3万美元，该公司在上个季度又购买了241股。Kestra Consulting Services LLC在第一季度将其在西方制药服务公司的头寸提高了7.5%。Kestra Consulting Services LLC现在拥有这家医疗器械供应商3,124股股票，价值1,283,000美元，上个季度又购买了219股。最后，美国互惠资本管理有限责任公司在第一季度将其在西部制药服务公司的头寸提高了1.1%。美国互惠资本管理公司现在持有这家医疗器械供应商的9,904股股票，价值4,068,000美元，此前在上个季度又购买了104股。机构投资者持有该公司91.98%的股票。
West Pharmaceutical Services Stock Up 0.7 %
西部医药服务公司股票上涨0.7%
Shares of West Pharmaceutical Services stock opened at $269.93 on Tuesday. The business's 50 day simple moving average is $312.53 and its 200 day simple moving average is $330.25. West Pharmaceutical Services, Inc. has a 52-week low of $261.31 and a 52-week high of $475.00. The firm has a market cap of $19.99 billion, a PE ratio of 29.96, a P/E/G ratio of 1.08 and a beta of 1.18. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.41 and a current ratio of 3.13.
周二，西方制药服务公司的股票开盘报269.93美元。该业务的50日简单移动均线切入位在312.53美元，200日简单移动均线切入位在330.25美元。West Pharmtics Services，Inc.的52周低点为261.31美元，52周高位为475.00美元。该公司的市值为199.9亿美元，市盈率为29.96倍，市盈率为1.08倍，贝塔系数为1.18。该公司的负债权益比率为0.09，速动比率为2.41，流动比率为3.13。
Insider Buying and Selling
内幕买卖
In other West Pharmaceutical Services news, insider Silji Abraham sold 5,374 shares of the company's stock in a transaction on Monday, August 1st. The shares were sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the sale, the insider now directly owns 3,201 shares of the company's stock, valued at $1,100,919.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.60% of the stock is owned by corporate insiders.
在其他西方制药服务公司的消息中，内部人士Silji Abraham在8月1日星期一的一笔交易中出售了5374股该公司股票。这些股票的平均价格为343.93美元，总成交金额为1,848,279.82美元。出售后，这位内部人士现在直接持有该公司3201股股票，价值1100,919.93美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，可以通过这个超级链接访问。公司内部人士持有该公司0.60%的股份。
About West Pharmaceutical Services
关于西方医药服务公司
(Get Rating)
(获取评级)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
西方制药服务公司在美洲、欧洲、中东、非洲和亚太地区设计、制造和销售可注射药物和保健产品的容器和输送系统。它分为两个部分，专有产品和合同制造产品。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
- Oracle's Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
- 免费获取StockNews.com关于West Pharmtics Services(WST)的研究报告
- 甲骨文的短期痛苦可能是你的长期收益
- Lucid看起来像是电动汽车的赢家
- 仍然爱着它：投资者继续光顾麦当劳
- 联邦快递刚刚提供了一个买入机会吗？
- 自动区重新进入拉力赛模式，新高在望
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).
想看看还有哪些对冲基金持有WST吗？访问HoldingsChannel.com获取西方制药服务公司(纽约证券交易所代码：WST-GET Rating)的最新13F文件和内幕交易。
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.
接受《西部医药服务报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对West Pharmtics Services和相关公司的最新新闻和分析师评级的每日简要摘要。